BR6914329D0 - Processo para a preparacao de 1h-(4,5-b)pirazin-2-onas - Google Patents
Processo para a preparacao de 1h-(4,5-b)pirazin-2-onasInfo
- Publication number
- BR6914329D0 BR6914329D0 BR214329/69A BR21432969A BR6914329D0 BR 6914329 D0 BR6914329 D0 BR 6914329D0 BR 214329/69 A BR214329/69 A BR 214329/69A BR 21432969 A BR21432969 A BR 21432969A BR 6914329 D0 BR6914329 D0 BR 6914329D0
- Authority
- BR
- Brazil
- Prior art keywords
- pirazin
- onas
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77747868A | 1968-11-20 | 1968-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR6914329D0 true BR6914329D0 (pt) | 1973-02-22 |
Family
ID=25110370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR214329/69A BR6914329D0 (pt) | 1968-11-20 | 1969-11-19 | Processo para a preparacao de 1h-(4,5-b)pirazin-2-onas |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3567725A (pt) |
| AT (1) | AT290528B (pt) |
| BE (1) | BE741910A (pt) |
| BR (1) | BR6914329D0 (pt) |
| DE (2) | DE1965989A1 (pt) |
| FR (1) | FR2035817B1 (pt) |
| GB (1) | GB1246006A (pt) |
| IL (1) | IL33336A0 (pt) |
| NL (1) | NL6915957A (pt) |
| ZA (1) | ZA698081B (pt) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8810934D0 (en) * | 1987-05-26 | 1988-06-15 | Ici America Inc | Amides |
| GB8810933D0 (en) * | 1987-05-26 | 1988-06-15 | Ici America Inc | Heterocyclic compounds |
| US5705585A (en) | 1993-06-30 | 1998-01-06 | Arqule, Inc. | Aminimide-containing molecules and materials as molecular recognition agents |
| US7034110B2 (en) * | 1994-01-05 | 2006-04-25 | Arqule, Inc. | Method of identifying chemical compounds having selected properties for a particular application |
| JPH09507852A (ja) * | 1994-01-05 | 1997-08-12 | アーキュール，インコーポレーテッド | 特定の性質を有するポリマーの製造方法 |
| US5734082A (en) * | 1994-10-20 | 1998-03-31 | Arqule Inc. | Hydroxyethyl aminimides |
| US5712171A (en) * | 1995-01-20 | 1998-01-27 | Arqule, Inc. | Method of generating a plurality of chemical compounds in a spatially arranged array |
| WO1996031263A1 (en) * | 1995-04-06 | 1996-10-10 | Arqule, Inc. | Method for rapid purification, analysis and characterization of collections of chemical compounds |
| US5962412A (en) * | 1996-06-10 | 1999-10-05 | Arqule, Inc. | Method of making polymers having specific properties |
| ES2381215T3 (es) * | 2006-10-19 | 2012-05-24 | Signal Pharmaceuticals Llc | Compuestos heteroarilo, sus composiciones y métodos de tratamiento con ellos |
| US8110578B2 (en) | 2008-10-27 | 2012-02-07 | Signal Pharmaceuticals, Llc | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway |
| EP2493472B1 (en) * | 2009-10-26 | 2016-12-07 | Signal Pharmaceuticals, LLC | Methods of synthesis and purification of heteroaryl compounds |
| EP2768500B1 (en) | 2011-10-19 | 2019-08-21 | Signal Pharmaceuticals, LLC | Treatment of cancer with tor kinase inhibitors |
| KR102040997B1 (ko) | 2011-12-02 | 2019-11-27 | 시그날 파마소티칼 엘엘씨 | 7-(6-(2-히드록시프로판-2-일)피리딘-3-일)-1-((트랜스)-4-메톡시시클로헥실)-3,4-디히드로피라지노[2,3-b]피라진-2(1H)-온, 그의 고체 형태의 제약 조성물 및 그의 사용 방법 |
| BR112014020786A2 (pt) | 2012-02-24 | 2020-10-27 | Signal Pharmaceuticals, Llc | método para tratamento de câncer de pulmão, método para alcançar um critério de avaliação de resposta em tumores sólidos, método para aumento da sobrevivência |
| AU2013203714B2 (en) | 2012-10-18 | 2015-12-03 | Signal Pharmaceuticals, Llc | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity |
| AU2014207641A1 (en) | 2013-01-16 | 2015-08-06 | Signal Pharmaceuticals, Llc | Substituted Pyrrolopyrimidine Compounds, compositions thereof, and methods of treatment therewith |
| WO2014172426A1 (en) | 2013-04-17 | 2014-10-23 | Signal Pharmaceuticals, Llc | Treatment of cancer with dihydropyrazino-pyrazines |
| KR102240356B1 (ko) | 2013-04-17 | 2021-04-14 | 시그날 파마소티칼 엘엘씨 | Ｔｏｒ 키나제 억제제와 5-치환된 퀴나졸리논 화합물을 포함하는 암 치료용 조합 요법 |
| TWI631949B (zh) | 2013-04-17 | 2018-08-11 | 標誌製藥公司 | 使用ｔｏｒ激酶抑制劑組合療法以治療癌症之方法 |
| KR102221005B1 (ko) | 2013-04-17 | 2021-02-26 | 시그날 파마소티칼 엘엘씨 | 전립선암 치료를 위한 디하이드로피라지노-피라진 화합물 및 안드로겐 수용체 길항제를 포함하는 조합 요법 |
| CN105339008A (zh) | 2013-04-17 | 2016-02-17 | 西格诺药品有限公司 | 用于治疗癌症的包括tor激酶抑制剂和n-(3-(5-氟-2-(4-(2-甲氧基乙氧基)苯基氨基)嘧啶-4-基氨基)苯基)丙烯酰胺的组合疗法 |
| EA030726B1 (ru) | 2013-04-17 | 2018-09-28 | СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | ФАРМАЦЕВТИЧЕСКИЕ СОСТАВЫ, СПОСОБЫ, ТВЕРДЫЕ ФОРМЫ И СПОСОБЫ ПРИМЕНЕНИЯ, ОТНОСЯЩИЕСЯ К 1-ЭТИЛ-7-(2-МЕТИЛ-6-(1H-1,2,4-ТРИАЗОЛ-3-ИЛ)ПИРИДИН-3-ИЛ)-3,4-ДИГИДРОПИРАЗИНО[2,3-b]ПИРАЗИН-2(1H)-ОНУ |
| NZ629332A (en) | 2013-04-17 | 2017-05-26 | Signal Pharm Llc | Treatment of cancer with dihydropyrazino-pyrazines |
| GB201309508D0 (en) | 2013-05-28 | 2013-07-10 | Redx Pharma Ltd | Compounds |
| CA3143529A1 (en) | 2013-05-29 | 2014-12-04 | Signal Pharmaceuticals, Llc | Pharmaceutical compositions 0f 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use |
| NZ714742A (en) | 2014-04-16 | 2017-04-28 | Signal Pharm Llc | Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use |
| EP3131552B1 (en) | 2014-04-16 | 2020-07-15 | Signal Pharmaceuticals, LLC | Methods for treating cancer using tor kinase inhibitor combination therapy |
| US9718824B2 (en) | 2014-04-16 | 2017-08-01 | Signal Pharmaceuticals, Llc | Solid forms comprising 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, and a coformer, compositions and methods of use thereof |
| WO2015160880A1 (en) | 2014-04-16 | 2015-10-22 | Signal Pharmaceuticals, Llc | SOLID FORMS COMPRISING 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL) PYRIDIN-3-YL)-3,4-DIHYDROPYRAZINO(2,3-b)PYRAZIN-2(1H)-ONE, AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF |
| NZ629796A (en) | 2014-07-14 | 2015-12-24 | Signal Pharm Llc | Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use |
| AU2015289929A1 (en) | 2014-07-14 | 2017-03-02 | Signal Pharmaceuticals, Llc | Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof |
| AU2018289539B2 (en) | 2017-06-22 | 2024-07-04 | Celgene Corporation | Treatment of hepatocellular carcinoma characterized by hepatitis B virus infection |
-
1968
- 1968-11-20 US US777478A patent/US3567725A/en not_active Expired - Lifetime
-
1969
- 1969-10-22 NL NL6915957A patent/NL6915957A/xx unknown
- 1969-11-10 IL IL33336A patent/IL33336A0/xx unknown
- 1969-11-17 DE DE19691965989 patent/DE1965989A1/de active Pending
- 1969-11-17 DE DE19691957711 patent/DE1957711A1/de active Pending
- 1969-11-17 GB GB56181/69A patent/GB1246006A/en not_active Expired
- 1969-11-19 BR BR214329/69A patent/BR6914329D0/pt unknown
- 1969-11-19 AT AT1082569A patent/AT290528B/de not_active IP Right Cessation
- 1969-11-19 BE BE741910D patent/BE741910A/xx unknown
- 1969-11-19 ZA ZA698081*A patent/ZA698081B/xx unknown
- 1969-11-20 FR FR696939941A patent/FR2035817B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2035817A1 (pt) | 1970-12-24 |
| IL33336A0 (en) | 1970-01-29 |
| GB1246006A (en) | 1971-09-15 |
| BE741910A (pt) | 1970-05-19 |
| US3567725A (en) | 1971-03-02 |
| AT290528B (de) | 1971-06-11 |
| ZA698081B (en) | 1971-07-28 |
| DE1957711A1 (de) | 1970-06-18 |
| NL6915957A (pt) | 1970-05-22 |
| FR2035817B1 (pt) | 1973-01-12 |
| DE1965989A1 (de) | 1971-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR6914329D0 (pt) | Processo para a preparacao de 1h-(4,5-b)pirazin-2-onas | |
| BR6785894D0 (pt) | Processo para preparacao de 1,2,3,4-tetrahidro-7-halo-6-sulfamil-4-quinazolinonas | |
| BR7019570D0 (pt) | Processo para a preparacao de mercapto-alquil-alcoxi-silanas | |
| BR6915466D0 (pt) | Processo para a preparacao de peperazinil-alquilaminourac | |
| BR6908638D0 (pt) | Processo para a preparacao de organo-silano-penicilinas | |
| BR6909792D0 (pt) | Processo para a preparacao de hidro-uracilas halo-substituidas | |
| BR6914375D0 (pt) | Processo para a preparacao de benzindenos | |
| BR7019965D0 (pt) | Processo para a preparacao de imidazois | |
| BR6915286D0 (pt) | Processo para a preparacao de tiofeno-sulfonil-ureias | |
| BR6911601D0 (pt) | Processo para a preparacao de compostos complexos | |
| BR6912323D0 (pt) | Processo para a fabricacao de 4,6-dicloro-4,6 estradienos | |
| BR6911905D0 (pt) | Processo para a preparacao de imidazopirazinonas | |
| BR6913178D0 (pt) | Processo para a preparacao de 19-nor-esteroides | |
| BR6911906D0 (pt) | Processo para a preparacao de imidazopirazinonas | |
| BR6684443D0 (pt) | Processo para a preparacao de derivados de 1,4-benzodioxano | |
| BR6912482D0 (pt) | Processo para a preparacao de cromenopirazol | |
| BR6906644D0 (pt) | Processo para a preparacao de cromanois | |
| BR7016656D0 (pt) | Processo para a preparacao de gama-cianobutiraldiminas | |
| BR6915006D0 (pt) | Processo para a preparacao do di-n-oxido-aldeido de quinoxatina | |
| BR6906936D0 (pt) | Processo para a preparacao de 6,7-epoxi-citronelal | |
| BR6911648D0 (pt) | Processo para a preparacao de dibenzo-cidohepteno | |
| BR6915196D0 (pt) | Processo para a preparacao de 21-ennantato de galfa-fluor-16-fluormetileno-prednisolona | |
| BR6915362D0 (pt) | Processo para a preparacao de 2(tienil-3-amino)1,3-diazacicloalquenos | |
| BR6910486D0 (pt) | Processo para a preparacao de compostos 4-imino-1,4- dihidro-piridina | |
| BR6913680D0 (pt) | Processo para a preparacao de imidazois |